What does Atea Pharmaceuticals, Inc. do?

Jun 22 2025 06:25 PM IST
share
Share Via
Atea Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing antiviral therapeutics. As of March 2025, it has a market cap of $274.71 million and reported a net profit loss of $34 million.
Overview:
Atea Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics in the Pharmaceuticals & Biotechnology industry.

Financial Snapshot:
Most recent Net Profit: -34 Million (Quarterly Results - Mar 2025)
Market cap: USD 274.71 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -1.03
Return on Equity: -33.93%
Price to Book: 0.67

Contact Details:
Address: 125 SUMMER STREET, 16TH FLOOR, BOSTON MA : 02110
Tel: 1 857 2048109
Fax: 1 302 6555049
Website: https://ateapharma.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Atea Pharmaceuticals, Inc. overvalued or undervalued?
Jun 25 2025 08:40 AM IST
share
Share Via
How big is Atea Pharmaceuticals, Inc.?
Jun 22 2025 05:49 PM IST
share
Share Via